Position in MRK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,015,522
+$92,687 QoQ
Shares Held
15,685
-1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.50%
of 13F equity value
Holder Rank
#1,581
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MONETARY MANAGEMENT GROUP INC holds $39,611,391 across 9 Drug Manufacturers - General names. MRK ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,775 | $17,721,579 | |
| 2 | ABBV |
AbbVie Inc.
|
35,105 | $8,833,822 | |
| 3 | AMGN |
Amgen Inc
|
13,171 | $4,769,482 | |
| 4 | JNJ |
Johnson & Johnson
|
17,045 | $4,328,918 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
15,685 | $2,015,522 | |
| 6 | PFE |
Pfizer Inc
|
38,004 | $915,136 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
13,850 | $798,037 | |
| 8 | NVS |
Novartis AG
|
1,259 | $197,310 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,015,522 | 15,685 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,922,835 | 15,985 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,693,107 | 16,085 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,417,158 | 16,885 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,506,810 | 19,035 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,697,361 | 18,910 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,373,818 | 13,810 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,480,254 | 13,035 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,108,629 | 8,955 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $1,208,002 | 9,155 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,025,333 | 9,405 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $973,392 | 9,455 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,142,937 | 9,905 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,053,792 | 9,905 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,071,222 | 9,655 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $855,085 | 9,929 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $905,226 | 9,929 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $818,776 | 9,979 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $751,378 | 9,804 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $725,111 | 9,654 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $727,460 | 9,354 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,955,697 | 25,369 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $2,349,213 | 28,719 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,382,242 | 28,719 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,626,823 | 33,969 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $2,607,880 | 33,895 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||